Objective: Atrial fibrillation (AF) is a causative disease of thrombotic cerebral embolism, and anti-coagulant therapy is used for its prevention. Since the prevalence rate is expected to increase with age, we examined the prevalence rate of AF and current state of treatment in medical check-ups and examined the changes over time.
Methods: Based on the findings of 12-lead electrocardiograms (ECG) of 175,462 patients (86,923 males, 88,539 females) in 2017, the treatment rates were calculated from the prevalence of sex and age and by using a questionnaire. We also examined the change in AF prevalence for 5 years from 2013 to 2017.
Results: The prevalence of AF was 1.13% (1.81 in males, 0.47 in women) and increased with age. Furthermore, a higher percentage was observed in males at each age. The treatment rates were 55.7% for those below 60 years of age, 68.8% for those in their 60s, 66.6% for those in their 70s, and 63.9% for those aged 80 years and above. In patients aged 75 years or older with a CHADS2 score of 1 or more, the treatment ratio was 65.0%. The trend of the AF prevalence over time was 1.03% in 2013, 1.04% in 2014, 1.10% in 2015, 1.12% in 2016, and 1.13% in 2017. There was no difference observed in morbidity, probably due to the aging of the examinees.
Conclusions: The prevalence of AF was 1.13%, and was found to be higher in males and in older age groups. There are many untreated patients below 60 years of age, and approximately 35% cases above the age of 75 years remain untreated. Therefore, it is necessary to educate patients regarding the need for medical treatment.
View full abstract